SC 13D
SC 13D Filing
- Company
- Opus Genetics, Inc.
- Filed
- May 23, 2005
- Accession Number
- 0000893838-05-000145
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →